The state’s diagnosis rate for ADHD — a disease that limits a person’s ability to hold attention, focus or control impulsive behavior — is 11 percent. BCBSA’s report found nationally, 2.4 million commercially insured children have been diagnosed with ADHD, up 31 percent from 2010-17.
In a separate report also published in August, the Office of Inspector General found that more than 500,000 children covered by Medicaid who were newly prescribed medication for ADHD didn’t receive proper follow-up care. In addition, more than 3,500 Medicaid-enrolled children who were hospitalized with a primary diagnosis of ADHD didn’t receive adequate follow-up care. Fifty-four thousand children didn’t receive any behavioral therapy either, the report found.
OIG recommended that CMS work to improve outcomes for children with ADHD by creating systems to better ensure children will receive timely follow-up care, among other efforts.
Find the BCBSA report here.
Read the full OIG report here.
More articles on population health:
FDA pushes for graphic cigarette warnings
79% of adults experience stress related to mass shooting fears
CDC’s gun injury data is skewed, investigators find
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
